These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10787312)

  • 1. Focal neuropathy associated with cutaneous necrosis at the site of interferon-beta injection for multiple sclerosis.
    Créange A; Lefaucheur JP
    J Neurol Neurosurg Psychiatry; 2000 Mar; 68(3):395. PubMed ID: 10787312
    [No Abstract]   [Full Text] [Related]  

  • 2. Lobular panniculitis at the site of subcutaneous interferon beta injections for the treatment of multiple sclerosis can histologically mimic pancreatic panniculitis. A study of 12 cases.
    Ball NJ; Cowan BJ; Hashimoto SA
    J Cutan Pathol; 2009 Mar; 36(3):331-7. PubMed ID: 19032383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Necrotizing cutaneous lesions caused by interferon beta injections in a patient with multiple sclerosis.
    Feldmann R; Löw-Weiser H; Duschet P; Gschnait F
    Dermatology; 1997; 195(1):52-3. PubMed ID: 9267740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Extensive cutaneous-subcutaneous infiltration as a side-effect of interferon-beta injection].
    Ziegler VR; Kränke B; Soyer P; Aberer W
    Hautarzt; 1998 Apr; 49(4):310-2. PubMed ID: 9606633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dermal fibrosis and cutaneous necrosis after recombinant interferon-beta1a injection in a multiple sclerosis patient.
    Ozden MG; Erel A; Erdem O; Oztas MO
    J Eur Acad Dermatol Venereol; 2005 Jan; 19(1):112-3. PubMed ID: 15649205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe local skin reactions to interferon beta-1b in multiple sclerosis-improvement by deep subcutaneous injection.
    Nakamura Y; Kawachi Y; Furuta J; Otsuka F
    Eur J Dermatol; 2008; 18(5):579-82. PubMed ID: 18693165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Activation of psoriasis in patients undergoing treatment with interferon-beta].
    Navne JE; Hedegaard U; Bygum A
    Ugeskr Laeger; 2005 Aug; 167(32):2903-4. PubMed ID: 16109199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Panniculitis after subcutaneous injection of interferon beta in a multiple sclerosis patient.
    Heinzerling L; Dummer R; Burg G; Schmid-Grendelmeier P
    Eur J Dermatol; 2002; 12(2):194-7. PubMed ID: 11872423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of cutaneous necrosis during interferon-beta 1b (B-IFN) therapy in multiple sclerosis.
    Albani C; Albani G
    J Neurol Neurosurg Psychiatry; 1997 Apr; 62(4):418. PubMed ID: 9120466
    [No Abstract]   [Full Text] [Related]  

  • 10. Local pain during REBIF injection is not due to acidic pH.
    Buttmann M; Goebeler M; Rieckmann P
    J Neurol Neurosurg Psychiatry; 2004 Jul; 75(7):1078. PubMed ID: 15201384
    [No Abstract]   [Full Text] [Related]  

  • 11. Cutaneous ulcerations following subcutaneous interferon beta injection to a patient with multiple sclerosis.
    Inafuku H; Kasem Khan MA; Nagata T; Nonaka S
    J Dermatol; 2004 Aug; 31(8):671-7. PubMed ID: 15492442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of septal panniculitis secondary to interferon treatment.
    Ozuguz P; Kacar SD; Karaca S; Tokyol C
    Cutan Ocul Toxicol; 2014 Dec; 33(4):351-2. PubMed ID: 24641120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local reactions associated with subcutaneous injections of both beta-interferon 1a and 1b.
    García-F-Villalta M; Daudén E; Sánchez J; Fraga J; Ramo C; García-Díez A
    Acta Derm Venereol; 2001 May; 81(2):152. PubMed ID: 11501663
    [No Abstract]   [Full Text] [Related]  

  • 14. Embolia cutis medicamentosa following interferon beta injection.
    Koontz D; Alshekhlee A
    Mult Scler; 2007 Nov; 13(9):1203-4. PubMed ID: 17967846
    [No Abstract]   [Full Text] [Related]  

  • 15. Extracorporeal shock wave therapy for injection site panniculitis in multiple sclerosis patients.
    Stieger M; Schmid JP; Yawalkar N; Hunziker T
    Dermatology; 2015; 230(1):82-6. PubMed ID: 25502016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fixed drug eruption with interferon-beta-1b.
    Tai YJ; Tam M
    Australas J Dermatol; 2005 Aug; 46(3):154-7. PubMed ID: 16008645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous necrosis associated with recombinant interferon injection. Report of three cases with interferon beta-1b and review of the literature.
    Weinberg JM; Wolfe JT; Sood S; Saruk M; Rook AH; Spiers EM
    Acta Derm Venereol; 1997 Mar; 77(2):146-8. PubMed ID: 9111829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin K cream reduces reactions at the injection site in patients with relapsing-remitting multiple sclerosis treated with subcutaneous interferon beta - VIKING study.
    Lanzillo R; Moccia M; Carotenuto A; Vacchiano V; Satelliti B; Panetta V; Brescia Morra V
    Mult Scler; 2015 Aug; 21(9):1215-6. PubMed ID: 25662354
    [No Abstract]   [Full Text] [Related]  

  • 19. Severe septal panniculitis in a multiple sclerosis patient treated with interferon-beta.
    Mazzon E; Guarneri C; Giacoppo S; Rifici C; Tchernev G; Polimeni G; Wollina U
    Int J Immunopathol Pharmacol; 2014; 27(4):669-74. PubMed ID: 25572749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Will new injection devices for interferon β-1a s.c. affect treatment adherence in patients with multiple sclerosis? An expert opinion in the Middle East.
    Deleu D; Alsharoqi I; Al Jumah MA; Al Tahan AR; Bohlega S; Dahdaleh M; Inshasi J; Khalifa A; Szólics M; Yamout BI
    Int J Neurosci; 2011 Apr; 121(4):171-5. PubMed ID: 21329472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.